Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

ClinicalTrials.gov ID: NCT00099320

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00099320. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to compare the effects of twice-daily exenatide plus oral antidiabetic (OAD) agents and twice-daily placebo plus OAD with respect to glycemic control, as measured by hemoglobin A1c (HbA1c), in patients with type 2 diabetes who experience inadequate glycemic control with OAD alone.

Study identification

NCT ID
NCT00099320
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
182 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2004 (Type not available)
Primary completion
Aug 2005 (Actual)
Completion
Aug 2005 (Actual)
Last update posted
Feb 23, 2015

2004 – 2005

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
40
Facility City State ZIP Site status
Research Site Birmingham Alabama — —
Research Site La Jolla California — —
Research Site San Mateo California — —
Research Site Santa Barbara California — —
Research Site Spring Valley California — —
Research Site Hialeah Florida — —
Research Site Jacksonville Florida — —
Research Site Melbourne Florida — —
Research Site West Palm Beach Florida — —
Research Site Atlanta Georgia — —
Research Site Honolulu Hawaii — —
Research Site Idaho Falls Idaho — —
Research Site Chicago Illinois — —
Research Site Baton Rouge Louisiana — —
Research Site Kalamazoo Michigan — —
Research Site Troy Michigan — —
Research Site Butte Montana — —
Research Site McCook Nebraska — —
Research Site North Platte Nebraska — —
Research Site Omaha Nebraska — —
Research Site Scottsbluff Nebraska — —
Research Site Princeton New Jersey — —
Research Site Albuquerque New Mexico — —
Research Site Albany New York — —
Research Site New York New York — —
Research Site Rochester New York — —
Research Site Greenville North Carolina — —
Research Site Cleveland Ohio — —
Research Site Greenville South Carolina — —
Research Site Chattanooga Tennessee — —
Research Site Knoxville Tennessee — —
Research Site Dallas Texas — —
Research Site Georgetown Texas — —
Research Site San Antonio Texas — —
Research Site The Colony Texas — —
Research Site Olympia Washington — —
Research Site Renton Washington — —
Research Site Tacoma Washington — —
Research Site Charleston West Virginia — —
Research Site Huntington West Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00099320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 23, 2015 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.